Brief Company History
CardioGenics was founded in Toronto, Ontario in 1997 as a biotechnology company dedicated to the development of products for the In-Vitro-Diagnostics market to meet unfulfilled needs. At the heart of CardioGenics Platform is a core technology for improving testing sensitivity to POC products.
CardioGenics has harnessed its core technology to build a compact POC analyzer that employs the most sensitive detection technology, chemiluminescence.
